Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028090 · ClinicalTrials.gov registry record
Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System
A clinical trial, sponsored by C. R. Bard.
- Completed
- Registry status
- 182
- Enrollment target
NCT03028090 is a clinical trial that has completed, run by C. R. Bard. The registered enrollment target is 182 participants.
The verdict
NCT03028090 has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
Study Summary
This study was to gather real-time ECG data through the use of the SHERLOCK 3CG™ Tip Confirmation System (TCS), an electrocardiogram (ECG)-based peripherally-inserted central catheter (PICC) tip confirmation technology. The study was to promote the development of a software package (MODUS) that can accurately define the maximum P-wave on an ECG waveform. All study participants received PICCs as their standard of care.
Interventions
- DEVICE SHERLOCK 3CG™ Tip Confirmation System with MODUS Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028090
The ClinicalTrials.gov registry entry for NCT03028090 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SHERLOCK 3CG™ Tip Confirmation System with MODUS Software is the first listed.
NCT03028090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03028090 about?
NCT03028090 is a clinical study titled "Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System". This study was to gather real-time ECG data through the use of the SHERLOCK 3CG™ Tip Confirmation System (TCS), an electrocardiogram (ECG)-based peripherally-inserted central catheter (PICC) tip confirmation technology. The study was to promote the development of a software package (MODUS) that can ...
What is the current status of trial NCT03028090?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2013-11. Estimated completion is 2014-11.
What interventions are being tested in trial NCT03028090?
The interventions under investigation include: SHERLOCK 3CG™ Tip Confirmation System with MODUS Software (DEVICE).
Who is sponsoring clinical trial NCT03028090?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.